Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 29:14:888942.
doi: 10.3389/fnagi.2022.888942. eCollection 2022.

Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson's Disease

Hui-Hui Fan  1   2 , Bao-Qing Li  3 , Ke-Yun Wu  1 , Hai-Dan Yan  1 , Meng-Jie Gu  2 , Xing-Hao Yao  1 , Hao-Jia Dong  1 , Xiong Zhang  2 , Jian-Hong Zhu  1   2
Affiliations

Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson's Disease

Hui-Hui Fan et al. Front Aging Neurosci. .

Abstract

Background: Environmental substances such as pesticides are well-known in link with Parkinson's disease (PD) risk. Enzymes including cytochromes P450 (CYPs), esterases and glutathione S-transferases (GSTs) are responsible for the xenobiotic metabolism and may functionally compensate each other for subtypes in the same class. We hypothesize that the genetic effects of each class modulate PD risk stronger in a synergistic way than individually.

Methods: We selected 14 polymorphic loci out of 13 genes which encode enzymes in the classes of CYP, esterase, and GST, and recruited a cohort of 1,026 PD and control subjects from eastern China. The genotypes were identified using improved multiplex ligation detection reaction and analyzed using multiple models.

Results: A total of 13 polymorphisms remained after Hardy-Weinberg equilibrium analysis. None of the polymorphisms were independently associated with PD risk after Bonferroni correction either by logistic regression or genetic models. In contrast, interaction analyses detected increased resistance to PD risk in individuals carrying the rs12441817/CC (CYP1A1) and rs2070676/GG + GC (CYP2E1) genotypes (P = 0.002, OR = 0.393, 95% CI = 0.216-0.715), or carrying the GSTM1-present, GSTT1-null, rs156697/AG + GG (GSTO2) and rs1695/AA (GSTP1) genotypes (P = 0.003, OR = 0.348, 95% CI = 0.171-0.706). The synergistic effect of GSTs on PD was primarily present in females (P = 0.003). No synergistic effect was observed within genotypes of esterases.

Conclusion: We demonstrate a presence of synergistic but not individual impact on PD susceptibility in polymorphisms of CYPs and GSTs. The results indicate that the genetic interplay leads the way to PD development for xenobiotic metabolizing enzymes.

Keywords: Parkinsion’s disease; genetic association; metabolizing enzymes; polymorphism; synergistic effect.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

    1. Ahmadi A., Fredrikson M., Jerregard H., Akerback A., Fall P. A., Rannug A., et al. (2000). GSTM1 and mEPHX polymorphisms in Parkinson’s disease and age of onset. Biochem. Biophys. Res. Commun. 269 676–680. 10.1006/bbrc.2000.2338 - DOI - PubMed
    1. Allen M., Zou F., Chai H. S., Younkin C. S., Miles R., Nair A. A., et al. (2012). Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol. Neurodegener. 7:13. 10.1186/1750-1326-7-13 - DOI - PMC - PubMed
    1. Chan D. K., Mellick G. D., Buchanan D. D., Hung W. T., Ng P. W., Woo J., et al. (2002). Lack of association between CYP1A1 polymorphism and Parkinson’s disease in a Chinese population. J. Neural Transm. 109 35–39. 10.1007/s702-002-8234-8 - DOI - PubMed
    1. Chan D. K., Mellick G. D., Hung W. T., Woo J. (2003). Genetic and environmental risk factors and their interactions for Parkinson’s disease in a Chinese population. J. Clin. Neurosci. 10 313–315. 10.1016/s0967-5868(03)00014-6 - DOI - PubMed
    1. Chuang Y. H., Lill C. M., Lee P. C., Hansen J., Lassen C. F., Bertram L., et al. (2016). Gene-Environment Interaction in Parkinson’s Disease: coffee, ADORA2A, and CYP1A2. Neuroepidemiology 47 192–200. 10.1159/000450855 - DOI - PMC - PubMed